Workflow
钠钙玻璃管制瓶
icon
Search documents
正川股份: 2025年半年度报告
Zheng Quan Zhi Xing· 2025-08-22 16:29
重庆正川医药包装材料股份有限公司2025 年半年度报告 公司代码:603976 公司简称:正川股份 重庆正川医药包装材料股份有限公司 重庆正川医药包装材料股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确 性、完整性,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人邓勇、主管会计工作负责人邓勇及会计机构负责人(会计主管人员)肖汉容声 明:保证半年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 六、 前瞻性陈述的风险声明 √适用 □不适用 本报告所涉及的未来计划、发展战略等前瞻性陈述,不构成公司对投资者的实质承诺,请投 资者注意投资风险。 七、 是否存在被控股股东及其他关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况 否 九、 是否存在半数以上董事无法保证公司所披露半年度报告的真实性、准确性和完整性 否 十、 重大风险提示 公司已在本报告中详细 ...
正川股份收盘上涨1.92%,滚动市盈率76.42倍,总市值32.95亿元
Sou Hu Cai Jing· 2025-08-15 12:16
Core Viewpoint - Zhengchuan Co., Ltd. has a closing price of 21.79 yuan, with a rolling PE ratio of 76.42 times, indicating a higher valuation compared to the industry average [1] Company Summary - Zhengchuan Co., Ltd. specializes in the research, production, and sales of pharmaceutical packaging materials, including borosilicate glass tubes and pre-filled syringes [1] - The company is a member of the China Pharmaceutical Packaging Association and the National Packaging Standardization Technical Committee [1] - As of March 31, 2025, the number of shareholders is 18,803, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Financial Performance - In the first quarter of 2025, the company reported revenue of 162 million yuan, a year-on-year decrease of 34.24%, and a net profit of 10.91 million yuan, down 48.15% year-on-year [1] - The sales gross margin for the same period is 21.61% [1] Industry Summary - The average PE ratio for the medical device industry is 56.58 times, with a median of 39.97 times, placing Zhengchuan Co., Ltd. at the 96th position in the industry ranking [1][2] - The industry includes various companies with lower PE ratios, such as Jiuan Medical at 11.36 times and Yuyue Medical at 20.20 times [2]
正川股份收盘下跌3.30%,滚动市盈率74.98倍,总市值32.33亿元
Sou Hu Cai Jing· 2025-08-14 13:21
Company Overview - Zhengchuan Co., Ltd. closed at 21.38 yuan, down 3.30%, with a rolling PE ratio of 74.98 times and a total market value of 3.233 billion yuan [1] - The company specializes in the research, production, and sales of pharmaceutical packaging materials, including borosilicate glass tubes and sodium-calcium glass tubes [1] - Zhengchuan is a member of the China Pharmaceutical Packaging Association and the National Packaging Standardization Technical Committee [1] Financial Performance - For Q1 2025, the company reported revenue of 162 million yuan, a year-on-year decrease of 34.24%, and a net profit of 10.9141 million yuan, down 48.15% year-on-year [1] - The sales gross margin for the latest quarter was 21.61% [1] Shareholder Information - As of March 31, 2025, the number of shareholders was 18,803, a decrease of 638 from the previous period, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Comparison - The average PE ratio for the medical device industry is 55.76 times, with a median of 39.14 times, placing Zhengchuan at the 96th position in the industry ranking [1][2] - The industry average market value is 11.792 billion yuan, while the median is 5.679 billion yuan [2]
正川股份收盘下跌1.85%,滚动市盈率78.24倍,总市值33.73亿元
Sou Hu Cai Jing· 2025-08-12 10:52
Company Overview - Zhengchuan Co., Ltd. closed at 22.31 yuan, down 1.85%, with a rolling PE ratio of 78.24 times and a total market value of 3.373 billion yuan [1] - The company operates in the pharmaceutical packaging materials sector, focusing on the research, production, and sales of medicinal glass tubes and other packaging materials [1] - Main products include borosilicate glass tubes, soda-lime glass tubes, aluminum caps, pre-filled syringes, and cassette bottles [1] Financial Performance - For Q1 2025, the company reported revenue of 162 million yuan, a year-on-year decrease of 34.24%, and a net profit of 10.9141 million yuan, down 48.15% year-on-year, with a gross margin of 21.61% [1] Shareholder Information - As of March 31, 2025, the number of shareholders was 18,803, a decrease of 638 from the previous period, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Comparison - The average PE ratio for the medical device industry is 57.51 times, with a median of 41.25 times, placing Zhengchuan Co., Ltd. at the 96th position in the industry ranking [1][2] - Other companies in the industry have varying PE ratios, with the highest being 21.19 times for Antu Biology and the lowest at 11.26 times for Jiuan Medical [2]
正川股份收盘下跌3.18%,滚动市盈率79.12倍,总市值34.11亿元
Sou Hu Cai Jing· 2025-08-04 11:53
Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Zhengchuan Co., which is currently facing a decline in stock price and profitability [1][2] - As of August 4, Zhengchuan Co. closed at 22.56 yuan, down 3.18%, with a rolling PE ratio of 79.12 times, significantly higher than the industry average of 54.32 times [1] - The company's total market capitalization is 3.411 billion yuan, ranking 99th in the medical device industry based on PE ratio [1][2] Group 2 - Zhengchuan Co. reported a revenue of 162 million yuan for Q1 2025, reflecting a year-on-year decrease of 34.24%, and a net profit of 10.91 million yuan, down 48.15% year-on-year [1] - The company's sales gross margin stands at 21.61% [1] - Zhengchuan Co. specializes in the research, production, and sales of pharmaceutical packaging materials, including borosilicate glass tubes and pre-filled syringes [1]
正川股份收盘下跌2.18%,滚动市盈率81.71倍,总市值35.23亿元
Sou Hu Cai Jing· 2025-08-01 12:22
Company Overview - Zhengchuan Co., Ltd. closed at 23.3 yuan, down 2.18%, with a rolling PE ratio of 81.71 times and a total market value of 3.523 billion yuan [1] - The company specializes in the research, production, and sales of pharmaceutical packaging materials, including borosilicate glass vials and sodium-calcium glass vials [1] - Zhengchuan is a member of the China Pharmaceutical Packaging Association and the National Packaging Standardization Technical Committee [1] Financial Performance - For Q1 2025, the company reported revenue of 162 million yuan, a year-on-year decrease of 34.24%, and a net profit of 10.9141 million yuan, down 48.15% [1] - The sales gross margin for the same period was 21.61% [1] Shareholder Information - As of March 31, 2025, the number of shareholders was 18,803, a decrease of 638 from the previous period, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Comparison - The average PE ratio for the medical device industry is 53.65 times, with a median of 37.22 times, placing Zhengchuan at the 101st position in the industry ranking [1][2] - The industry includes various companies with lower PE ratios, such as Jiuan Medical at 11.01 times and Yingke Medical at 15.45 times [2]
正川股份收盘下跌3.61%,滚动市盈率77.78倍,总市值33.54亿元
Sou Hu Cai Jing· 2025-07-29 11:04
Company Overview - Zhengchuan Co., Ltd. closed at 22.18 yuan, down 3.61%, with a rolling PE ratio of 77.78 times and a total market value of 3.354 billion yuan [1] - The company specializes in the research, production, and sales of pharmaceutical packaging materials, including borosilicate glass tubes and pre-filled syringes [1] Financial Performance - For Q1 2025, the company reported revenue of 162 million yuan, a year-on-year decrease of 34.24%, and a net profit of 10.9141 million yuan, down 48.15% year-on-year, with a gross margin of 21.61% [1] Shareholder Information - As of March 31, 2025, the number of shareholders was 18,803, a decrease of 638 from the previous period, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Comparison - The average PE ratio for the medical device industry is 55.46 times, with a median of 37.74 times, placing Zhengchuan Co., Ltd. at 98th in the industry ranking [1][2] - The industry average market value is 11.547 billion yuan, while the median is 5.685 billion yuan [2]
正川股份收盘上涨6.68%,滚动市盈率80.69倍,总市值34.79亿元
Sou Hu Cai Jing· 2025-07-28 11:28
Group 1 - The core viewpoint of the articles highlights the performance and valuation of Zhengchuan Co., which has a current stock price of 23.01 yuan, up 6.68%, with a rolling PE ratio of 80.69, marking a new low in 635 days, and a total market capitalization of 3.479 billion yuan [1] - Zhengchuan Co. ranks 100th in the medical device industry, which has an average PE ratio of 55.28 and a median of 38.06 [1][2] - As of March 31, 2025, Zhengchuan Co. has 18,803 shareholders, a decrease of 638 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - The main business of Chongqing Zhengchuan Pharmaceutical Packaging Materials Co., Ltd. includes the research, production, and sales of pharmaceutical packaging materials such as borosilicate glass tubes and sodium-calcium glass tubes [1] - The latest quarterly report for 2025 shows that the company achieved an operating income of 162 million yuan, a year-on-year decrease of 34.24%, and a net profit of 10.9141 million yuan, down 48.15%, with a sales gross margin of 21.61% [1]
正川股份收盘下跌1.27%,滚动市盈率68.28倍,总市值29.44亿元
Sou Hu Cai Jing· 2025-07-23 12:47
Company Overview - Zhengchuan Co., Ltd. closed at 19.47 yuan, down 1.27%, with a rolling PE ratio of 68.28 times and a total market value of 2.944 billion yuan [1] - The company operates in the pharmaceutical packaging materials sector, focusing on the research, production, and sales of medicinal glass tubes and other packaging materials [1] - Main products include borosilicate glass tubes, soda-lime glass tubes, aluminum caps, pre-filled syringes, and cassette bottles [1] Financial Performance - For Q1 2025, the company reported revenue of 162 million yuan, a year-on-year decrease of 34.24%, and a net profit of 10.9141 million yuan, down 48.15% year-on-year [1] - The sales gross margin stood at 21.61% [1] Shareholder Information - As of March 31, 2025, the number of shareholders was 18,803, a decrease of 638 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Comparison - The average PE ratio for the medical device industry is 53.52 times, with a median of 37.14 times, placing Zhengchuan Co., Ltd. at the 93rd position in the industry ranking [1][2] - Other companies in the industry have varying PE ratios, with the highest being 19.34 times for Antu Bio and the lowest at 10.94 times for Jiuan Medical [2]
正川股份收盘下跌1.50%,滚动市盈率62.07倍,总市值26.76亿元
Sou Hu Cai Jing· 2025-06-05 11:08
Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Zhengchuan Co., which operates in the pharmaceutical packaging industry [1][2] - As of June 5, Zhengchuan Co. closed at 17.7 yuan, down 1.50%, with a rolling PE ratio of 62.07 times and a total market capitalization of 2.676 billion yuan [1] - The average PE ratio for the medical device industry is 50.97 times, with a median of 36.67 times, placing Zhengchuan Co. at the 95th position in the industry ranking [1][2] Group 2 - As of the first quarter of 2025, there are two institutional investors holding shares in Zhengchuan Co., with a total holding of 59.4013 million shares valued at 1.029 billion yuan [1] - The main business of Chongqing Zhengchuan Pharmaceutical Packaging Materials Co., Ltd. includes the research, production, and sales of pharmaceutical packaging materials such as borosilicate glass tubes and sodium-calcium glass tubes [1] - The latest financial report for the first quarter of 2025 shows that the company achieved an operating income of 162 million yuan, a year-on-year decrease of 34.24%, and a net profit of 10.9141 million yuan, a year-on-year decrease of 48.15%, with a sales gross margin of 21.61% [1]